AI, Innovation, and Confidentiality: Navigating Trade Secrets in Healthcare

By: Nailah Morris

As artificial intelligence (AI) reshapes healthcare delivery, organizations increasingly confront new questions about how to protect the proprietary systems, data, and models driving their innovations. In this evolving landscape, trade secret protection offers a flexible but nuanced approach to safeguarding intellectual assets without public disclosure.

This is a brief overview of trade secrets as they apply to AI in healthcare. It aims to outline the general legal framework, highlights common challenges in protecting AI-related innovations, and discusses practical strategies organizations may consider when assessing their own compliance and risk posture.

Understanding Trade Secrets in Healthcare AI

In broad terms, trade secrets refer to information that is not publicly known, confers economic value due to its secrecy, and is subject to reasonable efforts to maintain its confidentiality. In the healthcare and AI context, trade secrets might include:

• Predictive models used in diagnostics or treatment recommendations
• Training data and data-labeling methodologies
• Natural language processing tools within decision support systems
• Proprietary algorithms and workflow automations

Key Elements of Trade Secret Protection

While trade secret laws vary by jurisdiction, many are shaped by common frameworks like the Uniform Trade Secrets Act (UTSA) and the federal Defend Trade Secrets Act (DTSA). These laws typically consider several factors when determining if information qualifies as a trade secret:

• Non-public nature: The information is not generally known or readily ascertainable.
• Economic value: Its secrecy provides a competitive or commercial advantage.
• Reasonable protection measures: The owner has taken steps to maintain its confidentiality (e.g., NDAs, secure access protocols, or employee training).

It’s important to note that simply labeling information as a “trade secret” does not guarantee legal protection. The substance of what is protected and how is often scrutinized in legal proceedings.

Protecting AI-Driven Innovation: Unique Considerations

AI development introduces novel challenges for organizations seeking to maintain confidentiality over proprietary technologies. Examples of these challenges include:

• Reverse engineering or data scraping from AI outputs
• Prompt injection tactics aimed at exposing model behavior or logic
• Unauthorized access through account impersonation or credential misuse

In light of these risks, maintaining clear records of access control, data provenance, and internal policies may be crucial when asserting trade secret status in any future dispute or audit.

Common Operational Pitfalls

Organizations working with AI in healthcare may encounter several common hurdles:

• Vague or overbroad descriptions of what constitutes a trade secret
• Inadequate digital or physical access restrictions
• Lack of internal documentation describing how proprietary information is safeguarded
• Unclear or incomplete IP ownership clauses in employment or vendor agreements
• While these issues may not result in immediate legal exposure, they can complicate efforts to demonstrate that reasonable protection measures were in place.

Risk Mitigation and Process Recommendations

Organizations can consider several steps to support trade secret protection and reduce legal and compliance risks:

1. Asset Mapping
2. Identify and inventory systems, data, processes, and models that could potentially qualify as proprietary or confidential.
3. Policy Implementation
4. Develop and enforce internal policies covering data access, confidentiality, reverse engineering, and third-party integration protocols.
5. Contractual Protections
6. Ensure contracts with employees, contractors, and collaborators include clearly articulated confidentiality clauses and IP ownership provisions.
7. Security Controls
8. Use layered protections such as encryption, role-based access, audit logs, and secure development environments.
9. Training and Education
10. Provide training to relevant staff on data protection, confidentiality obligations, and information handling procedures.

These considerations are not exhaustive but can serve as a starting point for internal assessments and strategic planning.

Conclusion

As healthcare innovation increasingly incorporates complex AI systems, the ability to define, protect, and enforce trade secret rights has become a critical part of maintaining a competitive edge. While trade secret law offers a path to protecting proprietary technologies, it requires clarity, diligence, and proactive planning, particularly in a regulatory and ethical environment as sensitive as healthcare.

*****************************************************

It should be noted that I am not your lawyer (unless you have presently retained my services through a retainer agreement). This post is not intended as legal advice, it is purely educational and informational, and no attorney-client relationship shall result after reading it. Please consult your own attorney for legal advice. If you do not have one and would like to retain my legal services, please contact me using the contact information listed above.

All information and references made to laws, rules, regulations, and advisory opinions were accurate based on the law as it existed at this time, but laws are constantly evolving. Please contact me to be sure that the law which will govern your business is current. Thank you.